SELLAS Life Sciences Group (SLS) Ownership - Who owns SELLAS Life Sciences Group?
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLS showed earnings on May 13, 2025. You can read more about the earnings report here.